Newly synthesized interferon and its mRNA were membrane-associated in a human lymphoblastoid cell (Namalwa) that had been induced with Sendai virus. Treatment with zinc, which acts as an inhibitor of proteolytic cleavage, prevented interferon production. When cytoskeletal function was disrupted by adding both colchicine and cytochalasin B to the induced Namalwa cells, secretion of interferon was inhibited. It is concluded that after translation of the interferon mRNA, the newly synthesized interferon polypeptide is discharged into the lumen of the endoplasmic reticulum, and undergoes a proteolytic cleavage before it is secreted by a process involving the cytoskeleton.
INTRODUCTION
Recently, there has been much progress in the elucidation of events preceding the synthesis of interferon. It has been suggested by Marcus & Sekellick (1977) that the first event in type I interferon production is the presence of double-stranded RNA in the cytoplasm, which leads to derepression/induction of an interferon gene. Following derepression, a new mRNA is then produced which is translated into interferon (Reynolds et al. 1975; Pestka et al. I975) on membrane-bound ribosomes (Abreu & Bancroft, 1978) .
The subsequent steps of interferon production are much less well understood. Since interferon is a secreted protein it would be expected that its processing and export would be similar to that of other secretory proteins. Blobel & Dobberstein's (I975) signal hypothesis accounts for the segregation of membrane and cytosol proteins by postulating that the proteins that enter the membrane contain a hydrophobic signal peptide. This signal peptide interacts with a receptor on the endoplasmic reticulum while the protein is still being translated, and results in the nascent chain being vectorially discharged into the lumen of the endoplasmic reticulum. The signal hypothesis has been substantiated for a number of different proteins (for review, see Campbell, 1979) . The cytoskeleton, in particular the microtubules, has been implicated in the movement of proteins from the lumen of the endoplasmic reticulum and their secretion (Case, 1978) .
In the case of interferon, Falcoff et al. (1976) showed that newly synthesized human fibroblast interferon was associated with a membrane fraction. The role of the cytoskeleton in interferon secretion has been investigated by treating cells producing interferon with agents that disrupt microtubules (colchicine and vinblastine) or microfilaments (cytochalasin B and D) . The results have not been clear cut. Havell & Vil~ek 0975) showed that vinblastine but not colchicine inhibited interferon secretion from human fibroblasts. On the other hand, Ito et al. (I976) showed that either colchicine or cytochalasin B could inhibit interferon production at an early stage in the mouse system, but subsequently proposed that cytochalasin D might also inhibit a later stage (Ito et al. I978) .
In this paper we have investigated post-translational events in interferon production in human lymphoblastoid cells (Namalwa), by treatment of induced cells with inhibitors of proteolysis and agents that disrupt the cytoskeleton METHODS Materials. Cytochalasin B, colchicine, griseofulvin, tosylamide-2-phenylethylchloromethyl ketone (TPCK), vinblastine, chymotrypsin (2 × crystallized) and trypsin (2 × crystallized) were purchased from Sigma Chemical Co., London. Nocadazole was from Aldrich Chemical Co., Dorset and phosphoramidon and I,IO-phenanthroline were gifts from Dr A. J. Kenny and Dr S. Higgins respectively. Cytochalasin B was kept as a IO mg/ml solution in ethanol, while the other drugs were dissolved in RPMI 164o and all were stored at -20 °C. All other chemicals were of the highest grade available, aSS-methionine (9oo Ci/mmol) was obtained from The Radiochemical Centre, Amersham.
Interferon induction and assay. Namalwa cells were cultured, pretreated with I mMbutyric acid for 48 h and induced at a concentration of 2 × It ~ cells/ml with Sendal virus as previously described (Baker et al. I98o) . In order to assay the released interferon the cells were pelleted. When the intracellular titre of interferon was to be measured, the cells were washed three times in I ml of cold phosphate-buffered saline (PBS), lysed by addition of 3o/A concentrated HC1 diluted to 1 ml with medium (RPMI I64O containing 27o calf serum), and the cell debris was then removed by centrifugation. Interferon samples were then dialysed overnight at pH 2, and exhaustively dialysed at pH 7 to remove the drugs, before assaying by inhibition of virus nucleic acid synthesis in MDBK cells (Atherton & Burke, 1975) . Results are expressed in terms of the human leucocyte research reference standard preparation 69/19, of which 2 units is equivalent to I unit in the assay.
Protein labelling and gel analysis. Protein was labelled by pelleting 2 x io 5 cells, resuspending them in 2oo/~1 methionine-free RPMI I64o and incubating at 37°C for 15 min before addition of 5o/~Ci 35S-methionine. Incubation continued for a further It min before the ceils were spun down for analysis. The celIs were solubilized, and analysed on lO to 22-57 o polyacrylamide gels as previously described (Colman & Morser, I979) . TCA-precipitable counts were estimated by the method detailed by Baker et al. (I98O) .
RNA extraction and oocyte micro-injection. RNA was extracted from induced cells by the method of Morser et aL (1979) . After the RNA had been dissolved it was extracted twice with a water-saturated mixture of chloroform: butanol (4: I), before ethanol precipitation. It was dissolved at a concentration of 5 mg/ml in 5 mM-tris-HC1 pH 7"6, and batches of 2o Xenopus oocytes were micro-injected with 3 ° nl and the resultant interferon in the incubation medium was assayed .
Subcellular fractionation. At 9 h after induction, ceils were pelleted, washed once in cold PBS and allowed to swell in cold RSB (lO mM-NaCI, I mM-MgCI2, It mM-tris-HC1 pH 7"6) and homogenized by IO strokes of a tight-fitting Dounce homogenizer. All subsequent operations were carried out at 4 °C. The nuclei were pelleted (iooo g, Io rain), and centrifugation of the supernatant (25ooo g, 3o min) gave the 'free' (supernatant) and 'membrane' (pelle 0 fractions (Abreu & Bancroft, I978) . These were either assayed directly for interferon activity or the RNA was extracted from them by the method described above. * Namalwa ceils were induced and 9 h later membrane and cytosol fractions prepared. Interferon activity was then assayed.
Interferon secretion 1 I9
t The fractions were treated with o'5 mg/ml of each enzyme for 3 h at 4 °C in the presence or absence of t ~ NP4o .
~: The cytoplasmic fraction was treated with 50/tg/ml RNase for [ h at 4 °C before the membrane fraction was prepared.
§ Cells were treated with Ioo/zg/ml of puromycin before they were fractionated.
RESULTS

Association of interferon mRNA and interferon with membranes
Since interferon is a secreted protein, it would be expected that it would be synthesized on membrane-bound ribosomes (Blobel & Dobberstein, I975) . To test this prediction, a membrane fraction was prepared from Namalwa cells 9 h after interferon induction. This is the time after induction at which interferon synthesis is proceeding at its maximal rate (Morser et al. I979) . RNA was isolated from both the cytosol and membrane fraction and assayed for interferon mRNA activity by micro-injecting it into oocytes. The mRNA from the cytosol gave 3 2 units of interferon/~o oocytes while the mRNA from the membranes gave 2oo units of interferon/~o oocytes. Thus, over 8o~ of the interferon mRNA was found in the membrane fraction.
As well as the distribution of interferon mRNA, the distribution of interferon protein was investigated. If the fractions were assayed directly for interferon, 9o~o of it was detected in the vesicles (Table i) . Interferon might have been adventitiously associated with the membranes, but then it would not have been resistant to degradation by trypsin and chymotrypsin. When this was tested, the interferon in the membrane fraction was protected from the proteolytic activity of the enzymes unless the membranes had been disrupted after isolation by addition of a non-ionic detergent (I ~o NP4o), showing that the interferon was inserted into the lumen of the vesicles, and was not adventitiously adhering to them.
The presence of interferon in the membranes might depend on the integrity of the polysomes. This possibility was tested by disrupting the polysomes, either with RNase A which releases ribosomes by degradation of mRNA or with puromycin which causes premature termination releasing ribosomal subunits. The cytoplasm was treated with RNase A (50/~g/ml for I h at 4 °C) before the membranes were isolated. The interferon in the cytosol and membrane fractions was assayed, and it was found to be predominantly membrane-associated (Table 0 . This result was confirmed by treating the cells with puromycin 0oo/zg/ml; protein synthesis was 99~o inhibited) for 5 min before isolation of the membranes. The interferon was still present in them, confirming that polysome integrity was not necessary for interferon to remain within the membranes.
To test whether the entry of interferon into the membranes was a step leading to its secretion, protein synthesis was inhibited and the externalization of interferon was followed. Cells were treated for 30 min with too pg/ml cycloheximide, which inhibits protein syn- Membrane Cytosol medium 8 h untreated 64o 50 80oo0 8"5-9 h untreated 8oo 64 2oooo 8"5-9 h cycloheximide-treated 50 8 16oo * Namalwa cells were induced and 8"5 h later membrane and cytosol fractions were prepared. Some cells were washed three times with medium containing Ioo/~g/ml cycloheximide or control medium, and incubated for a further 3o rain in the presence or absence of cycloheximide. The fractions were isolated in the presence of cycloheximide when the cells had been treated with it, and the interferon was assayed. 4"3 O'I mM 8" 5 4"2 Zinc o"5 mM 3"8 z'3 * Namalwa cells were induced and 3"5 h later the agents were added at the concentration shown. Protein synthesis was measured at 5 h post-induction by incorporation of 35S-methionine into TCAprecipitable material, while interferon present in the incubation medium was assayed 8 h post-induction. thesis by more than 99"5~, before the membrane fraction was prepared and assayed for interferon activity. The interferon titre associated with them had fallen while-there was an equivalent amount present in the incubation medium (Table 2) . Thus, the interferon present in the membranes can be secreted, but ongoing protein synthesis is not required for this to occur. It is probable, therefore, that the pool of interferon in the membranes is the precursor of the secreted interferon.
Proteolytic cleavage of interferon is necessary for secretion
Most secreted proteins contain an N-terminal signal peptide which confers on them the ability to cross the membrane into the lumen of the endoplasmic reticulum (Blobel & Dobberstein, i975; Campbell, i979) . In many proteins this peptide is subsequently removed by proteolytic cleavage, and in some proteins further proteolytic action is necessary for the formation of an active product (Campbell, I979)-Four substances that had previously been reported to inhibit proteolytic cleavage of proteins were tested to see if they affected secretion of interferon from induced Namalwa cells. The substances were I,Io-phenanthroline (Steiner, I979), phosphoramidon (Umozawa & Aoyagi, I977), TPCK (Walsh & Wilcox, I97o) and zinc ions (Butterworth & Korant, I974) . Both TPCK and zinc ions prevented interferon production. Only zinc ions were suitable for further experiments because they did not completely inhibit protein synthesis at a concentration at which they were still active in preventing interferon formation (Table 3) It was decided to investigate further the effect of zinc ions on interferon production in Namalwa cells. The optimal concentration of zinc ions was determined and was shown to be Ioo/ZM, at which level there was no effect on the rate of protein synthesis (Fig. r a) . When the proteins synthesized by induced Namalwa cells were analysed by labelling them with radioactive methionine followed by displaying them on a polyacrylamide gel, no differences were found between zinc-treated and untreated cells. The efficacy of the zinc treatment was demonstrated by showing that the cleavage of Semliki Forest virus envelope proteins was inhibited under these conditions (Clegg et al. t976) . Accumulation of interferon ceased very rapidly after the addition of zinc ions to the medium (Fig. ~ b) . Indeed, the speed of action is comparable with that of cycloheximide. When cells were treated with either zinc ions or cycloheximide the intracellular pool of interferon was secreted (Fig. I b) . Thus, neither agent inhibits secretion of interferon. It had previously been reported that the effect of zinc was reversible (Gevaudan et al. t972) , but attempts to reverse the inhibition of interferon production by washing the cells several times in large volumes of medium failed.
Involvement of the cytoskeleton in interferon secretion
The role of the cytoskeleton in interferon secretion was investigated by the addition of inhibitors of cytoskeletal function. A wide range of substances that affect both microtubules (colchicine, griseofulvin, nocadazole and vinblastine) and microfilaments (cytochalasin B) were tested. No single inhibitor gave a substantial and reproducible inhibition of interferon secretion at non-toxic concentrations, although colchicine at the highest dose depressed yields in some experiments without inhibiting protein synthesis completely (Table 4 ). These concentrations of the drugs are known to impair cytoskeletal function, and hence, interferon secretion may not depend on a single element of the cytoskeleton. On those occasions when an inhibition of interferon secretion was observed, there was no corresponding accumulation of intracellular interferon.
If, however, a mixture of an inhibitor of the microfilaments (cytochalasin B) and microtubules (colchicine) was applied to the induced Namalwa cells an inhibition of interferon production could be detected with a much smaller effect on protein synthesis (Table 4) . Fig. 2 . Nanaalwa cells were induced and 3 h later 2 mM-colchicine and 2 5/tg/ml cytochalasin B were added (arrow) and interferon production was followed (D--[~; II -m, control) .
Again no increase in the intracellular titre of interferon was found (data not shown). The rate of interferon secretion was reduced to about I ~ of the untreated control after the addition of the inhibitors (Fig. 2) . This change could neither be accounted for by the small reduction in protein synthesis (5o~ decrease), nor were changes detected in the synthesis of any cellular proteins. Therefore, it is probable that the cytoskeleton is involved in interferon secretion.
Interferon mRNA levels in treated cells
It is possible that the results of both the zinc treatment and the treatment with the mixture of cytochalasin B and colchicine were obtained because they were affecting the process of the induction of interferon mRNA. This hypothesis was tested by extracting RNA from cells 9 h after induction that had had interferon production inhibited by both methods from 3"5 h after induction. It was assayed for interferon mRNA by microinjection into oocytes. The results showed that interferon mRNA was present in the Interferon secretion I23 Table 5 -Interferon mRNA present in treated cells Interferon Treatment unitsho oocytes* Control 320 + zinc o. i mM 400 + colchicine 2 mM-k cytochalasin B 25 pg/ml z5o * Namalwa cells were induced and treated 3"5 h later with zinc ions (o-I raM) or a mixture of colchicine (2 mM) and cytochalasin B (25/~g/ml). RNA was extracted at 9 h after induction and 3o nl of a solution at 5 mg/ml was micro-injected into oocytes in order to estimate its interferon mRNA activity.
same amounts in control and treated cells (Table 5) . Control experiments had shown previously that the relationship between the amount of RNA injected into the oocytes and the interferon produced was linear under these conditions. Thus, these treatments were not acting by reducing the levels of interferon mRNA in the induced Namalwa cells.
DISCUSSION
In this paper we have shown that newly synthesized interferon is transferred into a membrane fraction, from which it is subsequently secreted. Interferon mRNA is also mainly membrane-associated, suggesting that translation of interferon takes place on membrane-bound polysomes. These results are in agreement with those predicted for the behaviour of proteins containing a signal sequence (Blobel & Dobberstein, 1975) . Thus, interferon may have a signal sequence that ensures its vectorial transfer into the lumen of the endoplasmic reticulum. The DNA sequence determined from a cloned cDNA copy of leucocyte mRNA has been shown to have the information necessary to code for a signal peptide (Mantei et al. I98o) .
Many secretory proteins undergo a proteolytic cleavage removing their signal sequences, and some have further proteolytic events before they are activated. The prevention of interferon secretion by treatment with zinc ions, an inhibitor of some proteases, suggests that this is the case for interferon, but it is not possible in these experiments to distinguish between removal of the signal peptide and other cleavages.
The need to treat the cells with an inhibitor of both microfitaments and microtubules in order to observe an inhibition of interferon secretion is different from the results of Havell & Vil~ek U975). However, in their experiments they were studying human diploid fibroblasts, which grow attached to a substrate, while Ito et al. 0976, I978) found that treatment with a single inhibitor did not affect interferon secretion in mouse spleen cells, which, like Namalwa cells, are maintained as a suspension culture.
Use of inhibitors to reach these conclusions rests on the assumption that the observed changes are not due to side effects of the inhibitors. In particular, changes in the level of interferon mRNA could cause the same reduction in interferon titre. However, this was ruled out by measuring the amount of interferon mRNA present after treatment with the inhibitors. Therefore, neither the induction of interferon mRNA nor its transcription, processing or turnover were altered in these cells. Protein synthesis in treated cells was identical to that in control cells. Hence the inhibitors were probably not affecting interferon production at sites other than their primary sites of action.
When zinc ions or the combined cytochalasin B and colchicine treatments were used, no increase in the intracellular titre of interferon was observed. It may be that the precursor to interferon needs to be processed before it can be detected in the bioassay. However, this would not explain the results with the inhibitors of cytoskeletal function. An alternative explanation may be that failure to process or secrete the interferon leads to its intracellular degradation. This latter explanation is supported by similar results obtained by studying secretion of interferon and other proteins in oocytes (A. Colman & M. J. Morser, unpublished data).
The results presented in this paper show that the post-translational events in the synthesis of human lymphoblastoid interferon are similar to those of other secretory proteins. That is, the interferon enters the lumen of the endoplasmic reticulum, undergoes a proteolytic cleavage and is secreted by a process that requires the involvement of the cytoskeleton.
